KR880007077A - 조성물 - Google Patents

조성물 Download PDF

Info

Publication number
KR880007077A
KR880007077A KR870014565A KR870014565A KR880007077A KR 880007077 A KR880007077 A KR 880007077A KR 870014565 A KR870014565 A KR 870014565A KR 870014565 A KR870014565 A KR 870014565A KR 880007077 A KR880007077 A KR 880007077A
Authority
KR
South Korea
Prior art keywords
composition
pyrano
dioxo
quinoline
dihydro
Prior art date
Application number
KR870014565A
Other languages
English (en)
Inventor
피.라이트
Original Assignee
피존스 피엘시
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 피존스 피엘시 filed Critical 피존스 피엘시
Publication of KR880007077A publication Critical patent/KR880007077A/ko

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

내용 없음.

Description

조성물
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (12)

  1. 9-에틸-6,9-디히드로-4,6-디옥소-10-프로필-4H-피라노[3,2-g]퀴놀린-2,8-디카르복실산 또는 그의 제약상 허용되는 염 및 제약상 허용되는 보조제 또는 부형제로 되고, 직장 투여 또는 식도 투여에는 적합하지만 , 흡입에 의한 투여에는 적합하지 않은 형태의 제약 조성물.
  2. 제1항에 있어서, 제약상 허용되는 염이 나트륨염인 제약 조성물.
  3. 유효성분으로서 9-에틸-6,9-디히드로-4,6-디옥소-10-프로필-4H-피라노[3,2-g]퀴놀린-2,8-디카르복실산 또는 제약상 허용되는 그의 염 부형제로 되고, 단위 투여량 당 유효성분 25내지 1000mg을 함유하는 직장내 투여 또는 식도 투여에 적합한 형태의 제약 조성물.
  4. 전항 중, 어느 하나의 항에 있어서, 고상물 형태의 조성물.
  5. 제4항에 있어서, 정제 또는 당의정 형태의 조성물.
  6. 제4항에 있어서, 경질 또는 연질 캡슐 형태의 조성물.
  7. 제4항에 있어서, 좌제 형태의 조성물.
  8. 제1항 내지 제3항 중 어느 하나의 항에 있어서, 시럽제 형태의 조성물.
  9. 제1항 내지 제3항 중 어느 하나의 항에 있어서, 현탁액제 또는 분산제 형태의 조성물.
  10. 치료학적 유효량의 9-에틸-6,9-디히드로-4,6-디옥소-10-프로필-4H-피라노[3,2-g]퀴놀린-2,8-디카르복실산 또는 그의 제약상 허용되는 염을 하기 질환의 환자에게 투여하는 것으로 되는 영양부족, 국한성 엔티리티스, 원심성 대장염, 직장항문염, 소화성궤양화, 감응성 장증후군, 위장염 중에서 선택되는 위장관 질환의 치료방법.
  11. 치료학적 유효량의 9-에틸-6,9-디히드로-4,6-디옥소-10-프로필-4H-피라노[3,2-g]퀴놀린-2,8-디카르복실산 또는 그의 제약상 허용되는 염을 하기 질환의 환자의 위장관에 투여하는 것으로 되는 영양부족, 국한성 엔티리티스, 원심성 대장염, 직장항문염, 소화성궤양화, 감응성 장 증후군, 위장염으로 되는 군 중에서 선택되는 위장관 질환의 치료방법.
  12. 치료학적 유효량의 9-에틸-6,9-디히드로-4,6-디옥소-10-프로필-4H-피라노[3,2-g]퀴놀린-2,8-디카르복실산 또는 제약상 허용되는 그의 염을 하기 질환의 환자에게 투여하는 것으로 되는 편두통, 비염, 습진, 가역적인 폐쇄성 기도질환, 기관지초확장증, 아스페르길루습병, 석면침착증, 조루애호가 질환 및 농부의 폐로 되는 군중에서 선택되는 음식과 관련된 질병의 치료방법.
KR870014565A 1986-12-19 1987-12-19 조성물 KR880007077A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8630419 1986-12-19
GB868630419A GB8630419D0 (en) 1986-12-19 1986-12-19 Pharmaceutical formulation

Publications (1)

Publication Number Publication Date
KR880007077A true KR880007077A (ko) 1988-08-26

Family

ID=10609308

Family Applications (1)

Application Number Title Priority Date Filing Date
KR870014565A KR880007077A (ko) 1986-12-19 1987-12-19 조성물

Country Status (17)

Country Link
EP (1) EP0272057A3 (ko)
JP (1) JPS63233919A (ko)
KR (1) KR880007077A (ko)
AU (1) AU8319587A (ko)
BE (1) BE1000733A3 (ko)
CH (1) CH672599A5 (ko)
DK (1) DK669287A (ko)
FR (1) FR2608429A1 (ko)
GB (1) GB8630419D0 (ko)
GR (1) GR871915B (ko)
IE (1) IE873463L (ko)
IL (1) IL84857A0 (ko)
IT (1) IT8723114A0 (ko)
LU (1) LU87080A1 (ko)
NZ (1) NZ222966A (ko)
PT (1) PT86415B (ko)
ZA (1) ZA879416B (ko)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3787274T2 (de) * 1986-12-23 1994-01-27 Fisons Plc Pharmazeutische Präparate, die eine wässerige Lösung eines Pyranoquinolins enthalten.
GB2202145B (en) * 1987-03-17 1991-01-02 Fisons Plc Compositions of nedocromil for dermatological use.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA735221B (en) * 1972-08-07 1974-07-31 Upjohn Co Improved dosage regimen
ZA782473B (en) * 1977-05-04 1979-04-25 Fisons Ltd Benzo pyrano-quinolinones
GB2187953B (en) * 1986-03-15 1989-11-15 Fisons Plc Pharmaceutical formulation

Also Published As

Publication number Publication date
AU8319587A (en) 1988-06-23
IE873463L (en) 1988-06-19
EP0272057A2 (en) 1988-06-22
GB8630419D0 (en) 1987-01-28
LU87080A1 (fr) 1988-04-05
IL84857A0 (en) 1988-06-30
NZ222966A (en) 1990-03-27
PT86415A (en) 1988-01-01
GR871915B (en) 1988-04-05
IT8723114A0 (it) 1987-12-18
FR2608429A1 (fr) 1988-06-24
ZA879416B (en) 1988-10-26
BE1000733A3 (fr) 1989-03-21
DK669287D0 (da) 1987-12-18
CH672599A5 (ko) 1989-12-15
EP0272057A3 (en) 1989-01-11
JPS63233919A (ja) 1988-09-29
PT86415B (pt) 1990-11-20
DK669287A (da) 1988-06-20

Similar Documents

Publication Publication Date Title
US4661491A (en) Alfuzosine compositions and use
JPH06505725A (ja) 5−フルオロ−2’−デオキシ−3’−チアシチジンのb型肝炎治療への使用
US4152448A (en) Method and composition for the treatment of a condition of the gastro intestinal tract
JPH0920659A (ja) 炎症性腹部疾患のためのカッパ−アヘン製剤作働薬
US4211777A (en) Compositions comprising a compound having sodium cromoglycate activity and aminosalicylic acid
US4425363A (en) Treatment of tardive dyskinesia in mammals
KR880007077A (ko) 조성물
US20180125792A1 (en) Non-steroidal anti-inflammatory drugs for cough
WO2000024397A1 (fr) Composition de medicament immunomodulateur
JP3455633B2 (ja) 潰瘍性大腸炎の予防又は治療剤
US3574831A (en) Therapeutic heparin-sodium taurocholate compositions
JPS6365653B2 (ko)
JPS624229A (ja) 鎮痛及び消炎作用を有する医薬
Goldblatt et al. Studies on Experimental Hypertension: XVII. Experimental Observations on the Treatment of Hypertension
US6025393A (en) Method for treatment of inflammatory intestinal diseases
BR112021015101A2 (pt) Combinações terapêuticas e composições para o tratamento de doença inflamatória intestinal (ii)
JP2938579B2 (ja) 消化管壁保護剤
JP2000186040A (ja) 抗hiv感染症剤
US11639332B2 (en) Methods and compositions of isoindoline-1,3-dione and isoindole prodrugs useful for treating cancer, ulcerative colitis and related inflammatory diseases
RU2294204C1 (ru) Способ лечения язвенной болезни желудка и двенадцатиперстной кишки
JP2900056B2 (ja) 非ステロイド抗炎症剤により生じる胃疾患の予防用医薬組成物
US5135925A (en) Use of zinc acexamate in the prophylaxis of gastropathy induced by non-steroidal anti-inflammatory drugs
US3181993A (en) Water-soluble salicylic acid derivatives as analgesics and antipyretics
KR100198490B1 (ko) 간장질환 치료용 의약 조성물
SU1762932A1 (ru) Способ профилактики острой сердечной недостаточности при операци х с искусственным кровообращением

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid